Safety and Pregnancy Outcomes in Thrombocythemia Patients Exposed to XAGRID® (Anagrelide Hydrochloride) Compared to Other Treatments
Launched by SHIRE · Dec 4, 2007
Trial Information
Current as of June 05, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • High risk ET patients
- • Subjects who can give written informed consent.
- • Subjects taking cytoreductive therapy
- Exclusion Criteria:
- • Contraindications listed by the product being used.
- • Patient cannot be participating in another clinical trial.
About Shire
Shire, a global biotechnology company, specializes in developing innovative therapies for rare diseases and complex conditions. With a strong commitment to improving the lives of patients, Shire focuses on areas such as hematology, immunology, neuroscience, and genetic disorders. The company is dedicated to advancing clinical research and delivering breakthrough treatments that address unmet medical needs. Through collaboration and a patient-centric approach, Shire strives to enhance health outcomes and empower individuals affected by challenging health conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Copenhagen, , Denmark
Catania, , Italy
Perugia, , Italy
Reggio Emilia, , Italy
Barcelona, , Spain
Padova, , Italy
Trondheim, , Norway
Paris, , France
Valencia, , Spain
Madrid, , Spain
Odense, , Denmark
Roma, , Italy
Madrid, , Spain
Hamburg, , Germany
Genova, , Italy
Bath, , United Kingdom
Barcelona, , Spain
Pavia, , Italy
Belfast, , United Kingdom
Hull, , United Kingdom
Valencia, , Spain
Santa Cruz De Tenerife, , Spain
Santiago De Compostela, , Spain
Birmingham, , United Kingdom
Madrid, , Spain
Stockholm, , Sweden
Marseille, , France
Bobigny, , France
Genova, , Italy
Athens, , Greece
Athens, , Greece
Piraeus, , Greece
Paris, , France
Piacenza, , Italy
Athens, , Greece
Viborg, , Denmark
Napoli, , Italy
Kuopio, , Finland
Uddevalla, , Sweden
Ragusa, , Italy
Gerona, , Spain
Torino, , Italy
Helsinki, , Finland
Napoli, , Italy
Valencia, , Spain
Great Yarmouth, , United Kingdom
Mestre, , Italy
Limassol, , Cyprus
Esbjerg, , Denmark
Herlev, , Denmark
Roskilde, , Denmark
Vejle, , Denmark
Jyvaskyla, , Finland
Argenteuil Cedex, , France
Beauvais, , France
Brest Cedex, , France
Caen Cedex, , France
Creteil, , France
Dijon, , France
Eaubonne, , France
Grenoble Cedex 09, , France
Lens, , France
Lille Cedex, , France
Lille Cedex, , France
Limoges Cedex, , France
Lyon, , France
Nice, , France
Paris Cedex 10, , France
Paris Cedex 4, , France
Pessac, , France
Aschaffenburg, , Germany
Augsburg, , Germany
Dresden, , Germany
Erfurt, , Germany
Frankfurt/Main, , Germany
Hamburg, , Germany
Hornberg, , Germany
Koeln, , Germany
Koln, , Germany
Magdeburg, , Germany
Moers, , Germany
Muenchen, , Germany
Muenster, , Germany
Munchen, , Germany
Munich, , Germany
Recklinghausen, , Germany
Saarbruecken, , Germany
Saarbruecken, , Germany
Ulm, , Germany
Weiden, , Germany
Wilhelmshaven, , Germany
Athens, , Greece
Athens, , Greece
Athens, , Greece
Athens, , Greece
Athens, , Greece
Athens, , Greece
Athens, , Greece
Athens, , Greece
Athens, , Greece
Heraklion, , Greece
Ioannina, , Greece
Larissa, , Greece
Nicchia, , Greece
Patras, , Greece
Patra, , Greece
Thessaloniki, , Greece
Thessaloniki, , Greece
Thessaloniki, , Greece
Tullamore, , Ireland
Ancona, , Italy
Arezzo, , Italy
Bari, , Italy
Brescia, , Italy
Brindisi, , Italy
Civitanova Marche, , Italy
Fano, , Italy
Florence, , Italy
Foggia, , Italy
Genova, , Italy
L'aquila, , Italy
Modena, , Italy
Monza, , Italy
Napoli, , Italy
Novara, , Italy
Parma, , Italy
Pesaro, , Italy
Ravenna, , Italy
Rieti, , Italy
Rionero In Vulture, , Italy
Rome, , Italy
Rome, , Italy
Rome, , Italy
San Giovanni Rotondo, , Italy
Terni, , Italy
Torino, , Italy
Vigevano, , Italy
Amsterdam, , Netherlands
Fredrikstad, , Norway
Tromso, , Norway
Viken, , Norway
Vila Nova De Gaia, , Portugal
Barakaldo, , Spain
Lugo, , Spain
Madrid, , Spain
Murcia, , Spain
Salamanca, , Spain
Falun, , Sweden
Gavle, , Sweden
Jonkoping, , Sweden
Ljungby, , Sweden
Malmo, , Sweden
Orebro, , Sweden
Stockholm, , Sweden
Sundsvall, , Sweden
Uppsala, , Sweden
Vasteras, , Sweden
Bristol, , United Kingdom
Darlington, , United Kingdom
Doncaster, , United Kingdom
Dudley, , United Kingdom
London, , United Kingdom
North Shields, , United Kingdom
Shrewsbury, , United Kingdom
Patients applied
Trial Officials
Study Director
Study Director
Takeda
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials